Background: Apoptosis plays an important role in the normal development and homeostasis of metazoans. Aberrations in this process have been implicated in several major human diseases, but its molecular mechanism is poorly understood. In animals as diverse as humans and nematodes, the Bcl-2 oncoprotein prevents or delays apoptosis, whereas proteases of the interleukin-1␤-converting enzyme (ICE) family are required, suggesting that they are components of a conserved mechanism controlling the onset of apoptosis.
Background
Apoptosis, a form of cell death, has been proposed to play an important role in normal morphogenesis, tissue remodelling and the establishment of immune self-tolerance [1] . It is also the method of cell killing mediated by cytotoxic T lymphocytes, and is induced by ␥ or ultraviolet irradiation, viral infection, or exposure to a variety of cytotoxic drugs. Inappropriate apoptosis has been proposed to underlie many human degenerative diseases, whereas resistance to apoptosis may contribute to viral infection and neoplastic transformation [2, 3] .
Although a wide variety of stimuli can induce apoptosis, most cells undergoing the process exhibit a similar series of changes, suggesting a common biochemical mechanism. Following a stimulus that triggers the process, there is a latent phase during which no apparent changes are observed but the cells become committed to die. This period is often variable in length within a population of cells and may involve changes in gene expression. Subsequently, the cells undergo dramatic morphological changes that include plasma-membrane blebbing, chromatin condensation and nuclear fragmentation. In many cases, genomic DNA is severed into oligonucleosomal fragments that produce a characteristic ladder when separated on agarose gels.
The Bcl-2 oncoprotein delays or prevents apoptosis triggered by a variety of stimuli, indicating that it controls a common process [4, 5] . Genetic studies on the nematode Caenorhabditis elegans have identified a homologous gene, ced-9, which acts to suppress cell death during development [6, 7] . Importantly, human Bcl-2 is able to suppress apoptosis in ced-9 mutants [7, 8] , demonstrating the conserved nature of the mechanism modulated by Bcl-2. Bcl-2 is one of a family of related proteins found in mammalian cells, some of which function as death suppressors and others which promote apoptosis [4, 5] . These proteins have been proposed to function by forming homodimers and heterodimers [9] , but the mechanism of their action is unknown.
In contrast to ced-9, other genes are required in order for apoptosis to occur in C. elegans [10] . Deletion or mutation of the ced-3 gene completely blocks developmental cell death [11] . The ced-3 gene [12] encodes a cysteine protease related to interleukin-1␤ (IL-1␤)-converting enzyme (ICE), which cleaves pro-IL-1␤ at a specific aspartate residue [13, 14] . Although ICE itself can induce apoptosis when overexpressed in mammalian cells [15] , mice genetically deficient in ICE develop normally and, in most cases, cells from these animals are capable of undergoing apoptosis [16, 17] . However, a number of additional ICErelated proteases are present in mammalian cells which may play more central roles in apoptosis [18, 19] .
An early event during the apoptosis of many mammalian cells is the cleavage of poly(ADP-ribose) polymerase (PARP) from its active 116 kDa form to an 89 kDa fragment [20] [21] [22] [23] . The role of PARP in apoptosis is still not clear, but cleavage may inhibit DNA-repair processes [20] . Lazebnik et al. [21] showed that human PARP was cleaved at the site DEVD↓G (single-letter amino-acid code) which separates the DNA-binding domain from the catalytic domain. The protease activity responsible, which they called prICE, resembles ICE in its susceptibility to chemical inhibitors, but is distinct, because purified ICE did not cleave PARP efficiently. A PARP-cleaving protease, also referred to as apopain [22] or Yama [23] , has been identified recently as the product of the human CPP-32 gene [24] . Nicholson et al. [22] demonstrated that a potent inhibitor of CPP-32 derived from the cleavage site in PARP inhibits nuclear morphological changes and DNA cleavage as well as PARP cleavage in mammalian apoptotic cell lysates. Furthermore, the inhibitor blocks camptothecin-induced apoptosis of osteosarcoma cells. These results suggest that CPP-32 or a similar protease plays a key role in mammalian apoptosis. CPP-32 is one of a subfamily of ICE-related proteases more similar to Ced-3 than ICE. Other members of this subfamily that have been identified recently include Mch-2 [25] and Mch-3/ICE-LAP3 [26, 27] . Perhaps significantly, CPP-32, Ced-3 and Mch-3 all cleave PARP in vitro [22, 26, 28] , suggesting that they have similar substrate specificities. It is not yet clear, however, whether these proteases are functional homologues of Ced-3 or have distinct roles. Like other members of the ICE family, they are synthesised as precursors that are activated by cleavage at specific aspartate residues [18] , but the control of their processing and activation is unknown. One possibility is that they are activated sequentially, forming a proteolytic cascade.
A critical issue in understanding the molecular mechanism of apoptosis is to define the biochemical pathway leading to DNA cleavage and the roles of the Bcl-2 family and the apoptotic proteases. Recent experiments using cultured mammalian cells have have suggested that Bcl-2 works upstream of CPP-32 and Mch-3/ICE-LAP3 [29, 30] , in agreement with genetic studies in C. elegans which indicated that Ced-9 acts upstream of Ced-3 [10] . However, the temporal sequence of events during the onset of apoptosis and the relationship between Bcl-2 and apoptotic proteases remains to be determined. To address this problem, we have used a cell-free system, produced from Xenopus laevis eggs, which undergoes apoptotic chromatin condensation and DNA fragmentation synchronously after a lag period. Bcl-2 can inhibit the apoptotic process when added early in the lag period [31] . Concentrated extracts of Xenopus eggs maintain the intracellular balance of protein concentrations and enzyme activities, and have been shown to faithfully reproduce complex processes of the cell cycle and their control (for example, [32, 33] ). We find that apoptosis in this system requires the activity of proteases that have characteristics of the Ced-3 sub-family of ICE-related proteases. A protease that cleaves PARP is activated prior to chromatin condensation and DNA cleavage. Bcl-2 only functions before the activation of this protease and attenuates its activation. The cleavage of CPP-32 precursor is inhibited indirectly by Bcl-2, although the CPP-32 precursor-cleaving activity is generated late in apoptosis in this system. These results provide direct biochemical evidence that Bcl-2 can prevent or delay apoptosis by modulation of a temporal series of apoptotic proteases.
Results
Isolated HeLa cell nuclei added to concentrated Xenopus egg extracts arrested in interphase were found to be stable for up to 3 hours of incubation. In the majority of preparations, the extracts then exhibited apoptotic DNA cleavage observed as the appearance of polynucleosomal DNA fragments on agarose gels (Fig. 1a) . These changes were accompanied by chromatin condensation typical of apoptotic cells (Fig. 2b) . As found previously by Newmeyer et al. [31] , the addition of Bcl-2 (produced in Sf21 insect cells) at the start of the incubation completely inhibited subsequent DNA cleavage (Fig. 1b) and morphological changes (Fig. 2c) . Control Sf21 cell lysates immunodepleted of Bcl-2 or prepared from cells producing unrelated proteins (CDK4/cyclin D1) had no effect. These extracts therefore provide a useful cell-free system to study the mechanism of action of the Bcl-2 family. Protein synthesis was inhibited in the extracts by the presence of cyclohexamide, so the inhibitory effect of Bcl-2 was entirely posttranslational. Furthermore, the extracts were arrested in interphase and contained little or no mitotic cyclins, excluding a role for mitotic cyclin-dependent protein kinases in this process. Bcl-2 functions only during the early part of the lag period, well before any nuclear changes are apparent [31] ; the addition of Bcl-2 after 1.5 hours of incubation of the nuclei in the extract did not prevent subsequent apoptotic events and the appearance of DNA cleavage fragments when assayed 4 hours after the start of the experiment (Fig. 3a) , although Bcl-2 was stable in the extracts throughout the time course of incubation (data not shown).
To investigate the possible role of ICE-like proteases in the apoptotic process in this system, we used tetrapeptide aldehyde inhibitors based upon the sites of cleavage in substrate proteins. Ac-DEVD-CHO, a potent inhibitor of human CPP-32 protease (K i CPP-32 < 1 nM; [22] ) and probably other closely related proteases, is derived from the cleavage site in the substrate PARP [21] . When added at the start of the incubation, Ac-DEVD-CHO completely abolished DNA fragmentation at concentrations as low as 1 nM (Fig. 1c) . Ac-DEVD-CHO also prevented the nuclear morphological changes associated with apoptosis ( Fig. 2d) . In contrast, Ac-YVAD-CHO, another tetrapeptide aldehyde which potently inhibits ICE (K i ICE = 0.76 nM; K i CPP-32 = 12 M [22]), only inhibited DNA cleavage (Fig. 1c ) and chromatin condensation (Fig. 2e ) when added at 10 M, in agreement with studies using other cell-free systems and similar inhibitors derived from the cleavage site of interleukin-1␤ [21, 22, 34, 35] . The cysteine protease inhibitor E64 and the serine protease inhibitor TPCK had no effect, even at very high concentrations (Fig. 1c) . These results are consistent with the requirement for a protease activity with similar characteristics to the Ced-3 sub-family of ICE-related proteases for nuclear events of apoptosis in Xenopus egg extracts, as reported recently for human and chicken cell extracts [22] . Addition of Ac-DEVD-CHO at different times during the incubation of the extracts determined that protease activity was required up to 2.5 hours of incubation for subsequent DNA cleavage to occur (Fig. 3b) , considerably later than the point at which Bcl-2 ceased to function. This shows that Bcl-2 functions prior to Ac-DEVD-CHO-sensitive proteases in the temporal sequence of events during the onset of apoptosis.
The cleavage site in human PARP [21] is conserved in Xenopus PARP [36] , suggesting that Xenopus PARP may be a substrate for apoptotic protease activity in the egg extracts. To examine PARP-cleaving activity directly, we produced Xenopus PARP using an in vitro transcription/translation system. When added to the extracts, PARP was stable for up to 1 hour, after which time it was efficiently cleaved to produce a polypeptide similar in size to the 85 kDa fragment of human PARP produced by CPP-32 activity (Fig.  4a ) [20] [21] [22] [23] . This proteolysis was completely inhibited by Ac-DEVD-CHO added at the start of the incubation ( Sf21 cell lysates containing Bcl-2 were added to the extract at the start of the incubation, at 1/100 dilution. DNA cleavage was analyzed at the times indicated. (c) Inhibition of DNA cleavage by tetrapeptide aldehyde inhibitors added at the start of incubations. Protease inhibitors were added at the start of the incubation and DNA cleavage was assayed 4 h later. Ac-DEVD-CHO and Ac-YVAD-CHO were added at the concentrations shown; E64 and TPCK were at 100 M. PARP cleavage, with significant cleavage only occurring after 4 hours (Fig. 4b) . The cleavage of Xenopus PARP and its attenuation by Bcl-2 were not dependent on the presence of nuclei in the extracts, although when Hela nuclei were added, the human PARP contained in the nuclei was cleaved with very similar kinetics (data not shown).
These results suggested that Bcl-2 was inhibiting or delaying the appearance of a Xenopus apoptotic PARP protease activity, which we will refer to as XAPP. For a more quantitative assay of XAPP, we used a tetrapeptide derivative based upon the site of proteolysis in PARP, which undergoes a change in fluorescence when cleaved (Z-DEVD-AFC). XAPP was initially inactive in the extract, but was activated to a high level within 1 hour (Fig. 5a ). In contrast, no activity towards an ICE substrate (DABCYL-YVADAP-EDANS; [37] ) was observed (data not shown). This activation of XAPP was partially blocked by the prior addition of lysates of Sf21 cells expressing Bcl-2. When Bcl-2 protein was immunoprecipitated from these lysates, inhibition of XAPP activation was not observed (Fig. 5a ), whereas a mock depletion had no effect on their ability to prevent XAPP activation (data not shown). It is possible, however, that additional factors in the lysates were specifically codepleted with Bcl-2. Lysates from Sf21 cells infected with unrelated proteins (CDK4 and cyclin D1) did not inhibit the activation of XAPP (Fig. 5a ). The addition of lysates containing Bcl-2 3 hours after the start of the incubation had no effect on XAPP activity (although Ac-DEVD-CHO still inhibited XAPP efficiently at this time; Fig. 5b ), excluding the possibility that a direct inhibitor of XAPP, such as baculovirus p35 protein [28, 38] which might be present in the Sf21 cell lysates, was responsible. Together, these data suggest that Bcl-2 functions upstream in the apoptotic pathway to regulate the activation of XAPP, rather than simply as an inhibitor of XAPP.
In order to investigate the regulation by Bcl-2 of protease activation, and the relationship between XAPP and 1000 Current Biology 1996, Vol 6 No 8 CPP-32 (recently suggested to play a central role in the control of apoptosis in mammalian cells [22, 23] ), we produced the inactive 32 kDa precursor of human CPP-32 [24] in vitro. Formation of the active enzyme requires proteolytic cleavage to produce the two fragments of approximately 20 and 11 kDa found in cells undergoing apoptosis [22, 23, 39] . When added to the extracts at the start of incubation, the 32 kDa precursor was initially stable, but was later cleaved to the active fragments, indicating that CPP-32 precursor-cleaving activity was generated during the latent phase (Fig. 6) . However, this CPP-32 precursorcleaving activity was not present until 3-3.5 hours after the start of the incubation (Fig. 6a) , about 1.5 hours later than the time of PARP cleavage (Fig. 4a) . Prior addition of Bcl-2 completely inhibited CPP-32 precursor cleavage (Fig. 6b) , but Bcl-2 protein was only able to block the cleavage when added during the initial 1.5 hours of extract incubation (Fig. 6c) , the period during which it also functions to prevent subsequent DNA cleavage. This result suggested that Bcl-2 was inhibiting the generation of a CPP-32 precursor-cleaving activity rather than having a direct effect on the cleavage of CPP-32. We examined this further by adding Bcl-2 to extracts incubated to generate CPP-32 precursor-cleaving activity before CPP-32 precursor was added. Bcl-2 had no effect under these conditions, whereas Ac-DEVD-CHO, but not Ac-YVAD-CHO, completely blocked CPP-32 precursor cleavage (Fig. 6d) .
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Figure 4
Bcl-2 delays the cleavage of PARP in Xenopus egg extracts. Xenopus Non-infected lysate Ac-DEVD-CHO Bcl-2 lysate CDK4/CycD1 lysate Anti-Bcl-2-depleted lysate
Discussion
Using a cell-free system of Xenopus egg extracts, we have begun to define the temporal sequence of events during the apoptotic process that results in nuclear chromatin condensation and DNA cleavage (Fig. 7) . Although Xenopus eggs do not normally undergo apoptosis even in the absence of the survival signals required by most cells [1] , it is evident that the molecular components required for the process pre-exist in egg extracts. Nuclei added to the extracts are stable for several hours of incubation before undergoing changes typical of apoptosis. During this lag period, however, biochemical changes are occurring. We find that a protease activity that cleaves PARP is dramatically activated within 1 hour of incubation. This Xenopus apoptotic PARP protease activity, which we have called XAPP, is similar to Ced-3-related apoptotic proteases in its inhibitor sensitivity and its apparent substrate specificity, suggesting that such proteases are a universal component of the apoptotic mechanism. Interestingly, the precursor of a human Ced-3-related protease, CPP-32, when added to the extracts is cleaved to its active form late in the apoptotic process at about the same time as DNA cleavage occurs. Indeed, generation of a CPP-32 precursor-cleaving activity occurs after PARP cleavage is complete.
Although we do not know what initiates the apoptotic process in these extracts, a control point regulated by the Bcl-2 oncoprotein is present. We find that Bcl-2 is functional only during a period prior to the activation of XAPP. Indeed, Bcl-2 added to the extracts early in the lag phase attenuates the activation of XAPP. However, there is significant XAPP activation after prolonged incubation in the presence of Bcl-2. One possibility is that only a component of total XAPP activity is essential for apoptosis and that its activation is blocked efficiently by Bcl-2. This component might reflect a different gene product or a compartmentalized fraction. If XAPP is an ICE-related protease, its activation may be due to proteolytic cleavage. However, determination of the precise relationship of XAPP to other apoptotic proteases and its mechanism of activation will require molecular cloning.
Cleavage of human CPP-32 in the extracts is also blocked by early addition of Bcl-2. Importantly, Bcl-2 does not inhibit CPP-32 cleavage directly, and CPP-32-cleaving activity is generated 1.5 hours after Bcl-2 ceases to be effective. CPP-32 cleavage is inhibited by Ac-DEVD-CHO, indicating that this proteolytic activity may be due to a related enzyme. As there is a significant temporal gap between the initial activation of PARP-cleaving activity and the appearance of CPP-32-cleaving activity, there are probably at least two distinct proteases, possibly more, being activated in a temporal sequence. It remains to be determined whether XAPP activation is part of cascade leading to CPP-32 cleavage or a collateral event. A number of human proteases closely related to CPP-32 and Ced-3 have been identified; these may be part of an apoptotic cascade, but their individual roles are unknown at present. The mechanism by which Bcl-2 controls activation of 1002 Current Biology 1996, Vol 6 No 8
Figure 6
Cleavage of CPP-32 is inhibited indirectly by Bcl-2. apoptotic proteases remains unclear, but presumably Bcl-2 inhibits one of the initial events in the process, functioning at, or upstream of, the activation of XAPP. Importantly, this study establishes that control of apoptotic proteases by Bcl-2 does not require de novo protein synthesis and occurs in the absence of intact nuclei.
The decision to activate apoptotic proteases is critical in determining the survival of cells and is likely to be subject to tight controls. Other members of the Bcl-2 family, including pro-apoptotic proteins such as Bak and Bax, may act at the same cytoplasmic control point as Bcl-2. Changes in the expression of Bcl-2 family proteins or their activities, particularly the balance between pro-and antiapoptotic regulators may regulate the initiation of the apoptotic protease cascade. Changes in the expression of the death proteases themselves may also alter the predisposition of a cell to apoptosis, but their activation would still be modulated by Bcl-2 family proteins. This may explain the ability of Bcl-2 to protect cells against apoptosis triggered by the overexpression of ICE-related proteases in their precursor form [15] . To bypass the Bcl-2 control point, extracellularly mediated signals may activate the apoptotic proteases downstream of Bcl-2 directly, for instance by the introduction of an active protease such as granzyme B [39] , which occurs during cytotoxic T-cell mediated cell killing, or signals, as yet uncharacterized, from the Fas/Apo-1 receptor [37, [40] [41] [42] [43] . Although this study shows that Bcl-2 cannot block apoptosis after PARP-cleaving proteases have been activated, the pathway may be negatively regulated at other points by additional mechanisms. Viral proteins such as the cowpox virus serpin crmA [23] and p35 from baculovirus [28, 38] are able to inactivate apoptotic proteases directly, although it is not clear whether cellular homologues of these proteins exist. In addition to temporal regulation of the pathway, there may be a spatial regulation due to the subcellular distribution of components.
The downstream substrates of apoptotic proteases remain to be fully characterized. In this system, PARP cleavage occurs 2-3 hours before DNA fragmentation and may contribute to the process. However, inhibition of apoptotic proteases with Ac-DEVD-CHO after PARP cleavage has occurred still completely blocks DNA fragmentation. PARP cleavage is not sufficient for DNA fragmentation, therefore, suggesting that the proteolysis of other substrates is required after PARP cleavage. Some of these reactions may be catalyzed by the same enzymes that cleave PARP or by other proteases activated as part of a cascade. It is possible that CPP-32 plays an important role at this stage of the process. Additional nuclear proteins that have been identified as potential substrates for apoptotic proteases include lamins [44, 45] , topoisomerase 1 [46] , the 70 kDa component of the U1 small nuclear ribonucleoprotein [47] , protein kinase C␦ [48] and PITSLRE protein kinase [49] . The cleavage of a number of proteins may be required for the final coup de grace of DNA cleavage to be initiated [19] , although some substrates, rather than acting directly to bring about changes in nuclear morphology and chromatin structure, may be involved in switching off recovery processes such as DNA repair. Cleavage of other substrates may be inconsequential. To determine the roles of the targets of this apoptotic cascade, as well as the mechanism of its initiation, will require a thorough dissection of the function of each protein. This will be greatly facilitated by the use of cellfree systems such as the one used here.
Conclusions
The results of this study, together with genetic information from C. elegans and experiments using cultured mammalian cells, establish that the molecular mechanism of apoptosis involves the activation of a series of proteases that cleave specific substrates. The initiation of these essentially irreversible reactions that lead to cell death must be tightly controlled. Bcl-2 inhibits activation of the proteases, and this may account for its ability to delay or prevent apoptosis. Understanding precisely how Bcl-2 regulates the activation of apoptotic proteases may shed further light on the mechanism controlling the initiation of apoptosis and how it may be manipulated pharmacologically.
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Figure 7
Temporal regulation of events during apoptosis in Xenopus egg extracts. Bcl-2 is functional only during the period prior to XAPP activation. In the absence of Bcl-2, PARP is cleaved after 2 h incubation, but apoptotic protease activity inhibitable by Ac-DEVD-CHO is still required for subsequent nuclear changes at 2. 
Materials and methods
Preparation of Xenopus egg extracts and HeLa nuclei.
Xenopus egg extracts were prepared at 4°C as 10 000 g supernatants supplemented with an ATP-regenerating system, cytochalasin B, cyclohexamide and 5 % (v/v) glycerol [32, 33] . They were snap-frozen in 100 l aliquots and stored in liquid nitrogen. Incubations were initiated immediately after thawing the extracts at 23°C. Most extracts prepared in this way become apoptotic after 3-5 h of incubation, although some are stable for up to 12 h. However, aliquots of a particular extract showed highly reproducible kinetics. Extracts used in the experiments shown were matched for the timing of DNA fragmentation. We have found no evidence that variation in the period between the priming of oocyte growth and induction of ovulation [31] influences the state of the extract.
HeLa nuclei were prepared essentially as described by Wood and Earnshaw [50] and maintained at -80°C in storage buffer (10 mM PIPES, 80 mM KCl, 20 mM NaCl, 250 mM sucrose, 5 mM EGTA, 1 mM DTT, 0.5 mM spermidine, 0.2 mM spermine, 1 g ml -1 protease inhibitors, 50 %(v/v) glycerol). Immediately after thawing, the nuclei were washed at 4°C in nuclear buffer (10 mM PIPES, 10 mM KCl, 2 mM MgCl 2 , 1 mM DTT, 10 M cytochalasin B, 1 g ml -1 aprotinin, 1 g ml -1 leupeptin, 1 g ml -1 pepstatin, 1 g ml -1 chymostatin, 1 g ml -1 antipain) and added to extracts at the start of incubation in 1/10 volume to give a final concentration of 1000 per l.
Agarose gel electrophoresis and SDS-PAGE analysis
During the incubation of extracts (typically 100 l) at 23°C, samples were removed for analysis of DNA or proteins. Samples for DNA analysis were prepared as follows: 10 l aliquots of extract were taken at the times indicated, added to 90 l lysis buffer (10 mM Tris pH 8.0, 100 mM EDTA, 0.5 % SDS, 200 g ml -1 proteinase K) and incubated overnight at 52°C. Samples were then phenol-extracted, ethanol-precipitated and run on 1 % agarose gels. Gels were then incubated in Tris-borate EDTA buffer containing 0.5 g ml -1 ethidium bromide and 300 g ml -1 RNase for 2 h. For analysis of proteins: 5 l aliquots of extract were added to 10 l SDS-PAGE gel sample buffer for SDS-PAGE. Gels were transferred to nitrocellulose for western immunoblotting or dried for autoradiography.
Microscopy
Aliquots (1 l) of extract were removed from incubations and mixed with 4 l fix buffer (10 % (v/v) formaldehyde, 50 % (v/v) glycerol, 100 mM NaCl, 2 mM KCl, 1 mM MgCl 2 , 0.1 mM EDTA, 1 g ml -1 Hoechst 33342, 5 mM HEPES, pH 7.8). Fluorescence microscopy was performed using a Zeiss Axiophot microscope.
Bcl-2 cloning and expression
A full length Bcl-2 cDNA was subcloned into the pVL1393 baculovirus vector (Invitrogen). Bcl-2 was expressed in Sf21 insect cells. Expression was confirmed by western immunoblotting (anti-Bcl-2 monoclonal antibody, Dako). Cell lysates containing Bcl-2 were prepared as described by Newmeyer et al. [31] and were added at 1/100 dilution to the extracts. This gave a final concentration comparable to that in transfected MuTu Burkitt's lymphoma cells, as determined by antibody detection. Immunodepletion experiments were carried out using the same antibody and protein A agarose beads.
Inhibitors and substrates of ICE family proteases
Tetrapeptide aldehydes Ac-DEVD-CHO and Ac-YVAD-CHO (SNPE Ltd, Strasbourg) were dissolved in 100 mM Hepes, pH 7.4 and added to the extracts at the concentrations shown. The fluorogenic tetrapeptideaminofluorylcoumarin Z-DEVD-AFC (Enzyme Systems Products) was dissolved at 5 mM in dimethyl formamide and then diluted to 500 M in 100 mM Hepes, pH 7.4. Aliquots (9 l) of Xenopus egg extract were taken at the times indicated, 1 l of diluted Z-DEVD-AFC was added to give a final concentration of 50 M and the cleavage reaction was carried out at 23°C. Samples were then diluted to 2 ml in phosphatebuffered saline which abolished any further Z-DEVD-AFC cleaving activity. Free AFC was detected using a fluorimeter using an excitation wavelength of 400 nm and an emission wavelength of 505 nm. The reaction was linear with respect to time for at least 20 min in extracts that had been preincubated to give maximal protease activity. Values shown were measured after a reaction time of 10 min.
In vitro transcription/translation
The Xenopus PARP clone pBS-XLPARP (a generous gift from B. Saulier-Le Drean and M. Philippe) was expressed using a coupled in vitro transcription/translation system (Promega) with T3 polymerase and labelled with [ 35 S]-methionine (1000 Ci mmol -1 ) prior to incubation in the extracts. CPP-32 was cloned from HT1376 bladder cells by reverse transcriptase-PCR and subcloned into the pcDNA3 vector for expression using the coupled in vitro transcription/translation system described above with T7 polymerase.
